NEW YORK (GenomeWeb) – Wafergen Biosystems said after the close of the market on Monday that its fourth quarter revenues grew more than threefold year over year. 

The Fremont, Calif.-based firm recorded $1.6 million in total revenues for the three months ended Dec. 31, 2014, compared to $490,465 in Q4 2013. The increase was driven by a $600,000 increase in SmartChip revenues in the recently completed quarter, compared to the year-ago quarter, as well as $500,000 in Apollo revenues in Q4 2014, compared to zero in Q4 2013, Wafergen said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.